On July 25, 2025, Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs, stock code: 9887.HK) listed on the Main Board of the Stock Exchange of Hong Kong (HKEX). Leads Biolabs issued 36,862,500 H shares globally at an issue price of HKD 35 per share, raising approximately HKD 1.29 billion (taking into account the full exercise of the offer size adjustment option and subject to the 15% over-allotment option).